SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-20-003487
Filing Date
2020-12-31
Accepted
2020-12-31 09:30:15
Documents
3
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 6-K zk2025306.htm 6-K 10461
2 EXHIBIT 1 exhibit_1.htm EX-99 34443
3 image0.jpg GRAPHIC 11181
  Complete submission text file 0001178913-20-003487.txt   61361
Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: 6-K | Act: 34 | File No.: 001-35773 | Film No.: 201427643
SIC: 2834 Pharmaceutical Preparations